Robert Fishman

Robert Fishman

Geen lopende functies
64 jaar
Health Technology
Consumer Services
Health Services

Profiel

Robert Stephen Fishman worked as Director-Clinical Affairs at Heartport, Inc. from 1995 to 1998.
He then worked as Vice President-Scientific Affairs at Aerogen, Inc. from 1998 to 2005.
From 2005 to 2007, he was Senior Vice President-Clinical Development at Anthera Pharmaceuticals, Inc. He then worked as Vice President-Medical Affairs at Alexza Pharmaceuticals, Inc. from 2007 to 2009.
From 2012 to 2015, he was Senior Vice President-Clinical Development at InterMune, Inc. He worked as Chief Medical Officer at Corcept Therapeutics, Inc. from 2015 to 2019.
He also served as a Trustee at Boca Raton Regional Hospital, Inc. He is currently working as Chief Medical Officer at 4D Molecular Therapeutics, Inc. from 2020 to 2023.
He previously worked as Chief Medical Officer at Xoc Pharmaceuticals, Inc. from 2019 to 2020.
Dr. Fishman received his undergraduate degree from Harvard University and his doctorate from Stanford University School of Medicine.

Eerdere bekende functies van Robert Fishman

BedrijvenFunctieEinde
4D MOLECULAR THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 13-04-2023
Hoofd Techniek/Wetenschap/O&O 01-10-2020
CORCEPT THERAPEUTICS INCORPORATED Hoofd Techniek/Wetenschap/O&O 31-01-2019
INTERMUNE INC Hoofd Techniek/Wetenschap/O&O 01-03-2015
ANTHERA PHARMACEUTICALS, INC. Hoofd Techniek/Wetenschap/O&O 01-01-2007
Ervaring van Robert Fishman in detail bekijken

Opleiding van Robert Fishman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

51

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Robert Fishman
-40 %: de beste tools exclusief voor abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU